Company / FCF Margin
Entera Bio Ltd. FCF Margin History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest FCF Margin
-3768.5%
FY2025
5-year range
-9362.7% / -1590.2%
FY2021-FY2025
Trend
-
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from -1590.2% to -3768.5% over the past 3 years.
Based on SEC 10-K filings.
-3768.5% in FY2025 with a 3-year CAGR of -2178.3%.
Declined from -1590.2% to -3768.5% over the past 3 years.
FCF Margin over time
Growth rates
- 3-Year Change
- -2178.3pp
- 5-Year Change
- -
- 10-Year Change
- -
Company context
Key Data Points
- Altman Z-Score -0.83 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | FCF MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -3768.5% | - |
| FY2024 | - | - |
| FY2023 | -9362.7% | -488.8% |
| FY2022 | -1590.2% | +45.3% |
| FY2021 | -2906.8% | - |
As of FY2025 · SEC 10-K Annual Filings · Updated Jun 24, 2026